Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » funding

funding

ADVERTISEMENT
News and Trends

BigHat Biosciences raises $75M to design safer, more effective antibodies

A company developing safer, more effective antibody therapies for patients using machine learning and synthetic…

By Liza Laws
July 20, 2022 - 4 minutes
News and Trends

FORTY51 Ventures closes $43M biotech fund and announces first investment

FORTY51 Ventures has announced the closing of FORTY51 Ventures I, raising $43 million in its…

By Jim Cornall
July 18, 2022 - 3 minutes
News and Trends

Financing round of $21M completed for drug to treat autoimmune diseases

The first-round of financing to the tune of $21 million (€20.6 million), for a drug…

By Liza Laws
July 11, 2022 - 3 minutes
News and Trends

Biosyntia closes a €11.5M round to launch world’s first bio-based vitamin B7

A bio-based vitamin B7 is the first product to be commercialized as biotech company, Biosyntia,…

By Liza Laws
July 8, 2022 - 3 minutes
News and Trends

French Juvisé buys gastro product in €400M finance deal

French pharmaceutical company, Juvisé has just bought worldwide commercial rights to Pylera from US biopharmaceutical…

By Liza Laws
July 7, 2022 - 2 minutes
News and Trends

Funding doubled for company working on breakthrough auto-immune disease therapeutics

A Paris-based biotech company developing products for auto-immune diseases, announced today (June 30) that it…

By Liza Laws
June 30, 2022 - 3 minutes
News and Trends

Osivax gets €10M influenza vaccine grant

A grant of €10 million ($10.5 million) has been secured by pharmaceutical company Osivax to…

By Liza Laws
June 23, 2022 - 2 minutes
News and Trends

Shanghai biotech secures $80 million to advance products

A bio-manufacturing company based in Shanghai has bagged $80 million in funding to advance its…

By Liza Laws
June 23, 2022 - 2 minutes
News and Trends

Millions invested for progression of Lyme disease vaccine

Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. …

By Liza Laws
June 22, 2022 - 2 minutes
News and Trends

Biotech companies to benefit from Third Rock Ventures $1.1B fund

U.S. company Third Rock Ventures has closed Third Rock Ventures Fund VI, raising $1.1 billion. …

By Jim Cornall
June 15, 2022 - 2 minutes
News and Trends

New Forbion life sciences fund hits €470M

European life sciences venture capital firm Forbion, has announced the first €470M ($500M) close of…

By Jim Cornall
June 9, 2022 - 4 minutes
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast